Zkusit zdarma
BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

BMRN
Cena:
$ 54.09
-0.01 (-0.02%)
Valuace
8
Růst
85
Zdraví
60
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia

BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia

14:26 21-05-2026

BMRN's shares rise after Voxzogo hits the main goal in a late-stage hypochondroplasia study, support...

BioMarin Reveals Dwarfism Study Data, Stock Soars

BioMarin Reveals Dwarfism Study Data, Stock Soars

14:11 21-05-2026

BioMarin Pharmaceuticals Inc. (NASDAQ:BMRN) stock is trading higher on Thursday as the company is ce...

BioMarin's drug shows significant growth gains in children in late-stage trial

BioMarin's drug shows significant growth gains in children in late-stage trial

17:20 20-05-2026

BioMarin Pharmaceutical said on Wednesday its treatment for a rare condition that leads to ​short ...

BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia

BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia

16:20 20-05-2026

Study met primary endpoint, exceeding expectations with a highly statistically significant improveme...

BMRN Stock Down on Mixed Results From Rare Disease Therapy Study

BMRN Stock Down on Mixed Results From Rare Disease Therapy Study

14:01 19-05-2026

BioMarin shares fall after BMN 401 meets a biomarker goal but misses a key radiographic endpoint in ...

BioMarin's genetic disease therapy shows mixed results in late-stage study

BioMarin's genetic disease therapy shows mixed results in late-stage study

9:24 18-05-2026

BioMarin Pharmaceutical said on Monday its ​experimental treatment for a ‌rare genetic condition...

BioMarin: 'Strong Buy' On VOXZOGO Expansion And Amicus Acquisition

BioMarin: 'Strong Buy' On VOXZOGO Expansion And Amicus Acquisition

15:48 06-05-2026

BioMarin Pharmaceutical remains a "Strong Buy," driven by pipeline progress, strategic acquisitions,...

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

14:20 05-05-2026

BMRN misses Q1 EPS estimates despite a revenue beat, as charges and higher costs weigh on profits, w...

BioMarin Pharmaceutical Inc. (BMRN) Q1 2026 Earnings Call Transcript

BioMarin Pharmaceutical Inc. (BMRN) Q1 2026 Earnings Call Transcript

21:33 04-05-2026

BioMarin Pharmaceutical Inc. (BMRN) Q1 2026 Earnings Call Transcript...

Compared to Estimates, BioMarin (BMRN) Q1 Earnings: A Look at Key Metrics

Compared to Estimates, BioMarin (BMRN) Q1 Earnings: A Look at Key Metrics

20:30 04-05-2026

Although the revenue and EPS for BioMarin (BMRN) give a sense of how its business performed in the q...

BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates

BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates

18:20 04-05-2026

BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $0.76 per share, missing the Zack...

BioMarin Reports First Quarter 2026 Financial and Operating Results

BioMarin Reports First Quarter 2026 Financial and Operating Results

16:05 04-05-2026

First Quarter 2026 Total Revenues Increased Year-over-year to $766 million Increased Full-year 2026 ...

BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society's 2026 Annual Meeting

BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society's 2026 Annual Meeting

15:30 02-05-2026

VOXZOGO is the only approved treatment for children with achondroplasia starting at birth, with over...

BioMarin Completes Acquisition of Amicus Therapeutics

BioMarin Completes Acquisition of Amicus Therapeutics

8:44 27-04-2026

Acquisition Adds Galafold ® (migalastat) for Fabry Disease and Pombiliti ® (cipaglucosidase alfa-a...

BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET

BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET

7:30 27-04-2026

SAN RAFAEL, Calif., April 27, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today...

BioMarin Pharmaceutical Inc. $BMRN Stake Cut by Asset Management One Co. Ltd.

BioMarin Pharmaceutical Inc. $BMRN Stake Cut by Asset Management One Co. Ltd.

3:56 25-04-2026

Asset Management One Co. Ltd. reduced its holdings in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by...

BioMarin Announces Board Leadership Transition

BioMarin Announces Board Leadership Transition

16:23 21-04-2026

Ian T. Clark elected Chair of the Board; Richard A. Meier to retire SAN RAFAEL, Calif....

BioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes A Buy

BioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes A Buy

12:54 15-04-2026

BioMarin (BMRN) has declined over 12% since January 2025, despite prior optimism. The investment the...

BioMarin (BMRN) Down 13.6% Since Last Earnings Report: Can It Rebound?

BioMarin (BMRN) Down 13.6% Since Last Earnings Report: Can It Rebound?

12:31 25-03-2026

BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock?...

BioMarin stops mid-stage trials of bone disorder treatment

BioMarin stops mid-stage trials of bone disorder treatment

9:40 16-03-2026

BioMarin Pharmaceutical will discontinue mid-stage trials of its bone disorder treatment after repor...

close

BIOMARIN ANNOUNCES CLOSING OF PRIVATE OFFERING OF SENIOR NOTES

12-02-2026
SAN RAFAEL, CALIF., FEB. 12, 2026 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) ("BIOM...
Více zde

BIOMARIN ANNOUNCES PRICING OF PRIVATE OFFERING OF SENIOR NOTES AND COMPLETION OF SYNDICATION OF NEW SENIOR SECURED TERM LOAN FACILITY

29-01-2026
SAN RAFAEL, CALIF., JAN. 29, 2026 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) ("BIOM...
Více zde

BIOMARIN ANNOUNCES PROPOSED PRIVATE OFFERING OF SENIOR NOTES AND SYNDICATION OF NEW SENIOR SECURED TERM LOAN FACILITY

26-01-2026
SAN RAFAEL, CALIF., JAN. 26, 2026 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) ("BIOM...
Více zde

BIOMARIN APPOINTS ARPIT DAVÉ CHIEF DIGITAL AND INFORMATION OFFICER

12-01-2026
MR. DAVÉ BRINGS MORE THAN 20 YEARS OF EXPERIENCE IN CREATING ENTERPRISE VALUE THROUGH DIGITAL TRANS...
Více zde

BIOMARIN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE ON MONDAY, JANUARY 12, AT 11:15 AM PT / 2:15 PM ET, IN SAN FRANCISCO, CA

08-01-2026
SAN RAFAEL, CALIF., JAN. 8, 2026 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) TODAY A...
Více zde

VEEVA AND BIOMARIN FORM LONG-TERM STRATEGIC PARTNERSHIP

08-01-2026
PARTNERSHIP TO HELP BIOMARIN INCREASE SPEED AND EFFICIENCY IN DEVELOPING AND COMMERCIALIZING INNOV...
Více zde

AMICUS THERAPEUTICS INVESTMENT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF AMICUS THERAPEUTICS, INC. - FOLD

26-12-2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde

BIOMARIN TO ACQUIRE AMICUS THERAPEUTICS FOR $4.8 BILLION, EXPANDING POSITION AS A LEADER IN RARE DISEASES, ACCELERATING REVENUE GROWTH AND STRENGTHENING FINANCIAL OUTLOOK

19-12-2025
BIOMARIN TO GAIN GALAFOLD® (MIGALASTAT) FOR FABRY DISEASE AND POMBILITI® (CIPAGLUCOSIDASE ALFA-ATG...
Více zde

BIOMARIN TO PARTICIPATE AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE ON TUESDAY, NOVEMBER 18, 2025, AT 10:30 AM GMT IN LONDON, ENGLAND

11-11-2025
SAN RAFAEL, CALIF. , NOV. 11, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) TODAY...
Více zde

FDA ACCEPTS BIOMARIN'S PALYNZIQ® (PEGVALIASE-PQPZ) SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR PRIORITY REVIEW TO EXPAND USE TO ADOLESCENTS AGED 12-17 WITH PHENYLKETONURIA

29-10-2025
APPLICATION BASED ON POSITIVE RESULTS FROM PHASE 3 PEGASUS STUDY, WHICH DEMONSTRATED STATISTICALLY S...
Více zde

BIOMARIN REPORTS THIRD QUARTER 2025 RESULTS AND PROVIDES CORPORATE UPDATE

27-10-2025
RAISES FULL-YEAR 2025 TOTAL REVENUES GUIDANCE AT THE MIDPOINT; REAFFIRMS VOXZOGO FULL-YEAR OUTLOOK 2...
Více zde

BIOMARIN TO HOST THIRD QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON MONDAY, OCTOBER 27, 2025, AT 4:30PM ET

22-10-2025
SAN RAFAEL, CALIF. , OCT. 22, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) TODAY...
Více zde

BIOMARIN ANNOUNCES POSITIVE PIVOTAL PHASE 3 DATA FOR PALYNZIQ® (PEGVALIASE-PQPZ) IN ADOLESCENTS WITH PHENYLKETONURIA AT 15TH INTERNATIONAL CONGRESS OF INBORN ERRORS OF METABOLISM

06-09-2025
NEW DATA FROM PHASE 3 PEGASUS STUDY DEMONSTRATES A 49.7% DECREASE IN MEAN BLOOD PHE LEVELS IN ADOLES...
Více zde

BIOMARIN REPORTS STRONG SECOND QUARTER 2025 RESULTS AND RAISES FULL-YEAR GUIDANCE¹ FOR TOTAL REVENUES, NON-GAAP OPERATING MARGIN, AND NON-GAAP DILUTED EPS

04-08-2025
SECOND QUARTER 2025 TOTAL REVENUES OF $825 MILLION (+16% Y/Y AND +17% AT CONSTANT CURRENCY Y/Y) SECO...
Více zde

BIOMARIN ANNOUNCES APPOINTMENT OF IAN T. CLARK TO BOARD OF DIRECTORS

01-08-2025
SAN RAFAEL, CALIF. , AUG. 1, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) ANNOUN...
Více zde

BIOMARIN TO HOST SECOND QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON MONDAY, AUGUST 4, 2025, AT 4:30PM ET

22-07-2025
SAN RAFAEL, CALIF. , JULY 22, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) TODAY...
Více zde

BIOMARIN ANNOUNCES COMPLETION OF ACQUISITION OF INOZYME

01-07-2025
SAN RAFAEL, CALIF. , JULY 1, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) SAID T...
Více zde

BIOMARIN PRESENTS FIVE-YEAR PHASE 3 RESULTS REINFORCING LONG-TERM EFFICACY AND SAFETY OF ROCTAVIAN® (VALOCTOCOGENE ROXAPARVOVEC-RVOX) AT INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTASIS 2025 CONGRESS

24-06-2025
DATA FROM LONGEST AND LARGEST HEMOPHILIA GENE THERAPY STUDY DEMONSTRATES SUSTAINED FACTOR VIII EXPRE...
Více zde

INOZYME PHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF INOZYME PHARMA, INC. - INZY

21-05-2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde

BIOMARIN STRENGTHENS ENZYME THERAPY BUSINESS WITH ACQUISITION OF INOZYME PHARMA

16-05-2025
ACQUISITION IS STRONG STRATEGIC FIT FOR BIOMARIN, ADDING INZ-701, A PHASE 3 ENZYME REPLACEMENT THERA...
Více zde

BIOMARIN PRESENTS NEW DATA FOR VOXZOGO® (VOSORITIDE) IN CHILDREN WITH ACHONDROPLASIA AND OTHER SKELETAL CONDITIONS AT TWO INTERNATIONAL ENDOCRINOLOGY MEETINGS

12-05-2025
NEW DATA IN CHILDREN UNDER 5 YEARS WITH ACHONDROPLASIA SHOWED TREATMENT WITH VOXZOGO WAS ASSOCIATED ...
Více zde

BIOMARIN REPORTS FIRST QUARTER 2025 RESULTS AND REAFFIRMS FULL-YEAR GUIDANCE

01-05-2025
FIRST QUARTER 2025 TOTAL REVENUES OF $745 MILLION (+15% Y/Y AND +17% AT CONSTANT CURRENCY Y/Y) FIRST...
Více zde

BIOMARIN TO HOST FIRST QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON THURSDAY, MAY 1, 2025, AT 4:30PM ET

17-04-2025
SAN RAFAEL, CALIF. , APRIL 17, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) TODA...
Více zde

BIOMARIN ANNOUNCES POSITIVE PIVOTAL DATA FOR PALYNZIQ® (PEGVALIASE-PQPZ) IN ADOLESCENTS WITH PHENYLKETONURIA

02-04-2025
COMPANY PLANS TO SUBMIT FOR REGULATORY APPROVAL LATER THIS YEAR SAN RAFAEL, CALIF. , APRIL 2, 2025 /...
Více zde

BIOMARIN PRESENTS NEW DATA DEMONSTRATING FAVORABLE SAFETY AND STRONG ADHERENCE IN REAL-WORLD CLINICAL PRACTICE WITH VOXZOGO® (VOSORITIDE) IN CHILDREN UNDER 3 WITH ACHONDROPLASIA AT 2025 AMERICAN COLLEGE OF MEDICAL GENETICS AND GENOMICS (ACMG) ANNUAL CLINI

20-03-2025
NEW DATA ALSO TO BE PRESENTED FOR PALYNZIQ® (PEGVALIAISE-PQPZ), REINFORCING ITS VALUE IN SUSTAINING...
Více zde

BIOMARIN TO PRESENT AT THE TD COWEN 45TH ANNUAL HEALTHCARE CONFERENCE ON TUESDAY, MARCH 4 AT 6:50 AM PT / 9:50 AM ET IN BOSTON, MA

25-02-2025
SAN RAFAEL, CALIF. , FEB. 25, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) TODAY...
Více zde

BIOMARIN ANNOUNCES APPOINTMENT OF TIMOTHY P. WALBERT TO BOARD OF DIRECTORS

24-02-2025
SAN RAFAEL, CALIF. , FEB. 24, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) TODAY...
Více zde

BIOMARIN REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS; SETS FULL YEAR 2025 GUIDANCE

19-02-2025
STRONG EXECUTION AND OPERATIONAL TRANSFORMATION IN 2024 DELIVERED RECORD FULL YEAR RESULTS AND PROVI...
Více zde

BIOMARIN TO HOST FOURTH QUARTER AND FULL-YEAR 2024 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON WEDNESDAY, FEBRUARY 19, 2025, AT 4:30PM ET

05-02-2025
SAN RAFAEL, CALIF. , FEB. 5, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) TODAY ...
Více zde

BIOMARIN ANNOUNCES LEGAL ACTION AGAINST ASCENDIS PHARMA A/S IN EUROPEAN UNIFIED PATENT COURT

13-01-2025
SAN RAFAEL, CALIF. , JAN. 13, 2025 /PRNEWSWIRE/ -- BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) TODAY...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-12 00:00:008-KStáhnout
2026-01-29 00:00:008-KStáhnout
2026-01-26 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-12-22 00:00:008-KStáhnout
2025-12-19 00:00:008-KStáhnout
2025-12-17 00:00:008-KStáhnout
2025-10-28 00:00:0010-QStáhnout
2025-10-27 00:00:008-KStáhnout
2025-10-07 01:00:008-KStáhnout
2025-10-07 00:00:008-KStáhnout
2025-08-11 01:00:008-KStáhnout
2025-08-11 00:00:008-KStáhnout
2025-08-05 01:00:0010-QStáhnout
2025-08-05 00:00:0010-QStáhnout
2025-08-04 01:00:008-KStáhnout
2025-08-04 00:00:008-KStáhnout
2025-08-01 01:00:008-KStáhnout
2025-08-01 00:00:008-KStáhnout
2025-05-22 01:00:008-KStáhnout
2025-05-22 00:00:008-KStáhnout
2025-05-16 01:00:008-KStáhnout
2025-05-16 00:00:008-KStáhnout
2025-05-02 01:00:0010-QStáhnout
2025-05-02 00:00:0010-QStáhnout
2025-05-01 01:00:008-KStáhnout
2025-05-01 00:00:008-KStáhnout
2025-03-03 00:00:008-KStáhnout
2025-03-02 23:00:008-KStáhnout
2025-02-24 00:00:008-KStáhnout
2025-02-24 00:00:0010-KStáhnout
2025-02-23 23:00:008-KStáhnout
2025-02-23 23:00:0010-KStáhnout
2025-02-19 00:00:008-KStáhnout
2025-02-18 23:00:008-KStáhnout
2024-10-31 00:00:0010-QStáhnout
2024-10-30 23:00:0010-QStáhnout
2024-10-29 00:00:008-KStáhnout
2024-10-28 23:00:008-KStáhnout
2024-09-24 01:00:008-KStáhnout
2024-09-24 00:00:008-KStáhnout
2024-09-04 01:00:008-KStáhnout
2024-09-04 00:00:008-KStáhnout
2024-08-28 01:00:008-KStáhnout
2024-08-28 00:00:008-KStáhnout
2024-08-22 01:00:008-KStáhnout
2024-08-22 00:00:008-KStáhnout
2024-08-05 01:00:008-KStáhnout
2024-08-05 01:00:0010-QStáhnout
2024-08-05 00:00:008-KStáhnout
2024-08-05 00:00:0010-QStáhnout
2024-05-24 01:00:008-KStáhnout
2024-05-24 00:00:008-KStáhnout
2024-05-14 01:00:008-KStáhnout
2024-05-14 00:00:008-KStáhnout
2024-04-26 01:00:0010-QStáhnout
2024-04-26 00:00:0010-QStáhnout
2024-04-24 01:00:008-KStáhnout
2024-04-24 00:00:008-KStáhnout
2024-04-23 01:00:008-KStáhnout
2024-04-23 00:00:008-KStáhnout
2024-02-26 00:00:0010-KStáhnout
2024-02-25 23:00:0010-KStáhnout
2024-02-22 00:00:008-KStáhnout
2024-02-21 23:00:008-KStáhnout
2024-01-11 00:00:008-KStáhnout
2024-01-10 23:00:008-KStáhnout
2023-12-20 00:00:008-KStáhnout
2023-12-19 23:00:008-KStáhnout
2023-11-03 00:00:008-KStáhnout
2023-11-02 23:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-11-01 00:00:008-KStáhnout
2023-10-31 23:00:008-KStáhnout
2023-08-02 01:00:0010-QStáhnout
2023-08-02 00:00:0010-QStáhnout
2023-07-31 01:00:008-KStáhnout
2023-07-31 00:00:008-KStáhnout
2023-05-30 01:00:008-KStáhnout
2023-05-30 00:00:008-KStáhnout
2023-04-28 01:00:0010-QStáhnout
2023-04-28 00:00:0010-QStáhnout
2023-04-26 01:00:008-KStáhnout
2023-04-26 00:00:008-KStáhnout
2023-02-27 00:00:008-KStáhnout
2023-02-27 00:00:0010-KStáhnout
2023-02-26 23:00:008-KStáhnout
2023-02-26 23:00:0010-KStáhnout
2023-01-11 00:00:008-KStáhnout
2023-01-10 23:00:008-KStáhnout
2022-12-21 00:00:008-KStáhnout
2022-12-20 23:00:008-KStáhnout
2022-10-28 01:00:0010-QStáhnout
2022-10-28 00:00:0010-QStáhnout
2022-10-26 01:00:008-KStáhnout
2022-10-26 00:00:008-KStáhnout
2022-10-07 01:00:008-KStáhnout
2022-10-07 00:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 00:00:008-KStáhnout
2022-05-31 01:00:008-KStáhnout
2022-05-31 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 00:00:008-KStáhnout
2022-04-29 01:00:0010-QStáhnout
2022-04-29 00:00:0010-QStáhnout
2022-04-27 01:00:008-KStáhnout
2022-04-27 00:00:008-KStáhnout
2022-02-25 00:00:0010-KStáhnout
2022-02-24 23:00:0010-KStáhnout
2022-02-23 00:00:008-KStáhnout
2022-02-22 23:00:008-KStáhnout
2022-02-14 00:00:008-KStáhnout
2022-02-13 23:00:008-KStáhnout
2021-12-15 00:00:008-KStáhnout
2021-12-14 23:00:008-KStáhnout
2021-11-03 00:00:008-KStáhnout
2021-11-02 23:00:008-KStáhnout
2021-10-29 01:00:0010-QStáhnout
2021-10-29 00:00:0010-QStáhnout
2021-10-27 01:00:008-KStáhnout
2021-10-27 00:00:008-KStáhnout
2021-07-30 01:00:0010-QStáhnout
2021-07-30 00:00:0010-QStáhnout
2021-07-28 01:00:008-KStáhnout
2021-07-28 00:00:008-KStáhnout
2021-06-02 01:00:008-KStáhnout
2021-06-02 00:00:008-KStáhnout
2021-06-01 01:00:008-KStáhnout
2021-06-01 00:00:008-KStáhnout
2021-04-30 01:00:0010-QStáhnout
2021-04-30 00:00:0010-QStáhnout
2021-04-29 01:00:008-KStáhnout
2021-04-29 00:00:008-KStáhnout
2021-02-26 00:00:0010-KStáhnout
2021-02-25 23:00:0010-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-22 00:00:008-KStáhnout
2021-02-21 23:00:008-KStáhnout
2020-12-18 00:00:008-KStáhnout
2020-12-17 23:00:008-KStáhnout
2020-11-06 00:00:0010-QStáhnout
2020-11-05 23:00:0010-QStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-04 23:00:008-KStáhnout
2020-09-09 01:00:008-KStáhnout
2020-09-09 00:00:008-KStáhnout
2020-08-05 01:00:0010-QStáhnout
2020-08-05 00:00:0010-QStáhnout
2020-08-04 01:00:008-KStáhnout
2020-08-04 00:00:008-KStáhnout
2020-07-02 01:00:008-KStáhnout
2020-07-02 00:00:008-KStáhnout
2020-06-01 01:00:008-KStáhnout
2020-06-01 00:00:008-KStáhnout
2020-05-19 01:00:008-KStáhnout
2020-05-19 00:00:008-KStáhnout
2020-05-14 01:00:008-KStáhnout
2020-05-14 00:00:008-KStáhnout
2020-05-01 01:00:0010-QStáhnout
2020-05-01 00:00:0010-QStáhnout
2020-04-29 01:00:008-KStáhnout
2020-04-29 00:00:008-KStáhnout
2020-04-22 01:00:008-KStáhnout
2020-04-22 00:00:008-KStáhnout
2020-02-27 00:00:0010-KStáhnout
2020-02-26 23:00:0010-KStáhnout
2020-02-26 00:00:008-KStáhnout
2020-02-25 23:00:008-KStáhnout
2020-02-03 00:00:008-KStáhnout
2020-02-02 23:00:008-KStáhnout
2019-10-29 00:00:0010-QStáhnout
2019-10-28 23:00:0010-QStáhnout
2019-10-23 01:00:008-KStáhnout
2019-10-23 00:00:008-KStáhnout
2019-08-02 01:00:0010-QStáhnout
2019-08-02 00:00:0010-QStáhnout
2019-08-01 01:00:008-KStáhnout
2019-08-01 00:00:008-KStáhnout
2019-07-10 01:00:008-KStáhnout
2019-07-10 00:00:008-KStáhnout
2019-06-07 01:00:008-KStáhnout
2019-06-07 00:00:008-KStáhnout
2019-04-29 01:00:0010-QStáhnout
2019-04-29 00:00:0010-QStáhnout
2019-04-25 01:00:008-KStáhnout
2019-04-25 00:00:008-KStáhnout
2019-02-28 00:00:0010-KStáhnout
2019-02-27 23:00:0010-KStáhnout
2019-02-21 00:00:008-KStáhnout
2019-02-20 23:00:008-KStáhnout
2019-01-08 00:00:008-KStáhnout
2019-01-07 23:00:008-KStáhnout
2018-10-26 01:00:0010-QStáhnout
2018-10-26 00:00:0010-QStáhnout
2018-10-25 01:00:008-KStáhnout
2018-10-25 00:00:008-KStáhnout
2018-10-23 01:00:008-KStáhnout
2018-10-23 00:00:008-KStáhnout
2018-09-24 01:00:008-KStáhnout
2018-09-24 00:00:008-KStáhnout
2018-08-03 01:00:0010-QStáhnout
2018-08-03 00:00:0010-QStáhnout
2018-08-02 01:00:008-KStáhnout
2018-08-02 00:00:008-KStáhnout
2018-06-08 01:00:008-KStáhnout
2018-06-08 00:00:008-KStáhnout
2018-04-27 01:00:0010-QStáhnout
2018-04-27 00:00:0010-QStáhnout
2018-04-25 01:00:008-KStáhnout
2018-04-25 00:00:008-KStáhnout
2018-02-26 00:00:0010-KStáhnout
2018-02-25 23:00:0010-KStáhnout
2018-02-22 00:00:008-KStáhnout
2018-02-21 23:00:008-KStáhnout
2017-11-28 00:00:008-KStáhnout
2017-11-27 23:00:008-KStáhnout
2017-10-31 00:00:0010-QStáhnout
2017-10-30 23:00:0010-QStáhnout
2017-10-26 01:00:008-KStáhnout
2017-10-26 00:00:008-KStáhnout
2017-10-03 01:00:008-KStáhnout
2017-10-03 00:00:008-KStáhnout
2017-08-11 01:00:008-KStáhnout
2017-08-11 00:00:008-KStáhnout
2017-08-02 01:00:008-KStáhnout
2017-08-02 01:00:0010-QStáhnout
2017-08-02 00:00:008-KStáhnout
2017-08-02 00:00:0010-QStáhnout
2017-06-12 01:00:008-KStáhnout
2017-06-12 00:00:008-KStáhnout
2017-05-04 01:00:008-KStáhnout
2017-05-04 01:00:0010-QStáhnout
2017-05-04 00:00:008-KStáhnout
2017-05-04 00:00:0010-QStáhnout
2017-04-13 01:00:008-KStáhnout
2017-04-13 00:00:008-KStáhnout
2017-02-27 00:00:0010-KStáhnout
2017-02-26 23:00:0010-KStáhnout
2017-02-23 00:00:008-KStáhnout
2017-02-22 23:00:008-KStáhnout
2016-12-19 00:00:008-KStáhnout
2016-12-18 23:00:008-KStáhnout
2016-12-09 00:00:008-KStáhnout
2016-12-08 23:00:008-KStáhnout
2016-12-02 00:00:008-KStáhnout
2016-12-01 23:00:008-KStáhnout
2016-11-03 00:00:0010-QStáhnout
2016-11-02 23:00:0010-QStáhnout
2016-10-27 01:00:008-KStáhnout
2016-10-27 00:00:008-KStáhnout
2016-08-11 01:00:008-KStáhnout
2016-08-11 00:00:008-KStáhnout
2016-08-08 01:00:0010-QStáhnout
2016-08-08 00:00:0010-QStáhnout
2016-08-04 01:00:008-KStáhnout
2016-08-04 00:00:008-KStáhnout
2016-07-19 01:00:008-KStáhnout
2016-07-19 00:00:008-KStáhnout
2016-06-10 01:00:008-KStáhnout
2016-06-10 00:00:008-KStáhnout
2016-05-02 01:00:0010-QStáhnout
2016-05-02 00:00:0010-QStáhnout
2016-04-28 01:00:008-KStáhnout
2016-04-28 00:00:008-KStáhnout
2016-03-01 00:00:008-KStáhnout
2016-02-29 23:00:008-KStáhnout
2016-02-29 00:00:0010-KStáhnout
2016-02-28 23:00:0010-KStáhnout
2016-02-25 00:00:008-KStáhnout
2016-02-24 23:00:008-KStáhnout
2016-01-07 00:00:008-KStáhnout
2016-01-06 23:00:008-KStáhnout
2015-12-31 00:00:008-KStáhnout
2015-12-30 23:00:008-KStáhnout
2015-12-28 00:00:008-KStáhnout
2015-12-27 23:00:008-KStáhnout
2015-12-21 00:00:008-KStáhnout
2015-12-20 23:00:008-KStáhnout
2015-11-16 00:00:008-KStáhnout
2015-11-15 23:00:008-KStáhnout
2015-11-02 00:00:0010-QStáhnout
2015-11-01 23:00:0010-QStáhnout
2015-10-29 00:00:008-KStáhnout
2015-10-28 23:00:008-KStáhnout
2015-10-07 01:00:008-KStáhnout
2015-10-07 00:00:008-KStáhnout
2015-10-02 01:00:008-KStáhnout
2015-10-02 00:00:008-KStáhnout
2015-09-18 01:00:008-KStáhnout
2015-09-18 00:00:008-KStáhnout
2015-08-24 01:00:008-KStáhnout
2015-08-24 00:00:008-KStáhnout
2015-08-05 01:00:0010-QStáhnout
2015-08-05 00:00:0010-QStáhnout
2015-08-03 01:00:008-KStáhnout
2015-08-03 00:00:008-KStáhnout
2015-06-15 01:00:008-KStáhnout
2015-06-15 00:00:008-KStáhnout
2015-05-05 00:00:0010-QStáhnout
2015-04-30 00:00:008-KStáhnout
2015-03-05 23:00:008-KStáhnout
preloader